TOX as a potential target for immunotherapy in lymphocytic malignancies
Open Access
- 20 March 2021
- journal article
- review article
- Published by Springer Nature in Biomarker Research
- Vol. 9 (1) , 1-8
Abstract
TOX (thymocyte selection-associated HMG BOX) is a member of a family of transcriptional factors that contain the highly conserved high mobility group box (HMG-box) region. Increasing studies have shown that TOX is involved in maintaining tumors and promoting T cell exhaustion. In this review, we summarized the biological functions of TOX and its contribution as related to lymphocytic malignancies. We also discussed the potential role of TOX as an immune biomarker and target in immunotherapy for hematological malignancies.Keywords
Funding Information
- National Natural Science Foundation of China (81770152, 81570143, 82070152)
- Guangzhou Science, Technology and Innovation Commission (201807010004, 201803040017)
This publication has 53 references indexed in Scilit:
- The many roles of TOX in the immune systemCurrent Opinion in Immunology, 2012
- TOX regulates the differentiation of human natural killer cells from hematopoietic stem cells in vitroImmunology Letters, 2011
- Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue–inducer cell and NK cell lineagesNature Immunology, 2010
- Identification and Characterization of a Novel Human PP1 Phosphatase ComplexJournal of Biological Chemistry, 2010
- Role of RUNX3 in Bone Morphogenetic Protein Signaling in Colorectal CancerCancer Research, 2010
- HMGB proteins: Interactions with DNA and chromatinBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010
- Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box FactorsCell Stem Cell, 2009
- TOX3 regulates calcium-dependent transcription in neuronsProceedings of the National Academy of Sciences, 2009
- Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic LeukemiaScience, 2008
- Development of all CD4 T lineages requires nuclear factor TOXJournal of Experimental Medicine, 2008